Resonance Health Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RHT.AX research report →
Price Chart
About the company
Resonance Health Limited is a global provider of healthcare technology and services, specializing in the design, development, and production of software-as-medical devices. The company serves markets across the Asia Pacific, Americas, Europe, Middle East, and Africa. Its portfolio of non-invasive, MRI-based diagnostic tools includes FerriScan, a system for quantifying liver iron concentration (LIC); FerriSmart, leveraging artificial intelligence (AI) for automated, real-time assessment of LIC; HepaFat-AI, an AI-driven solution for real-time, multi-metric liver fat quantification; CardiacT2, which provides dual analysis in conjunction with FerriScan to evaluate cardiac iron accumulation; HepaFat-Scan, a non-invasive MRI method for assessing liver fat within tissue; and LiverSmart, a comprehensive non-invasive MRI device integrating FerriSmart and HepaFat-AI for a unified report.
- CEO
- Andrew Duncan Harrison
- IPO
- 2000
- Employees
- 18
- HQ
- Burswood, WA, AU
Get TickerSpark's AI analysis on RHT.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $28.63M
- P/E
- 37.50
- PEG
- -0.04
- P/S
- 2.07
- P/B
- 2.59
- EV/EBITDA
- 22.64
- Div Yield
- 0.00%
- Gross Margin
- 96.54%
- Op Margin
- 14.03%
- Net Margin
- 5.56%
- ROE
- 7.57%
- ROIC
- 12.95%
Latest fiscal year · YoY change
- Revenue
- $11.07M+28.9%
- Gross Profit
- $11.07M+28.9%
- Op Income
- $-1,928,764
- Net Income
- $-1,732,939-1123.6%
- EPS
- $-0.00-1050.0%
- OCF Growth
- -10.0%
- FCF Growth
- -20.3%
- 52W High
- $0.06
- 52W Low
- $0.03
- 50D MA
- $0.05
- 200D MA
- $0.05
- Beta
- 1.15
- RSI (14)
- 62
- Avg Volume
- 269.42K
No earnings-call transcripts are available for RHT.AX yet.
- Free Float
- 83.9%
- Shares Outstanding
- 477.12M
- Float Shares
- 400.35M
Our RHT.AX coverage
Recent articles, reports, and earnings notes.
No research on RHT.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RHT.AX report →